Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
06.02.24
/
50%
€387.70
Target price
06.02.25
€439.24
Performance (%)
7.05%
Price
17:24
€415.05
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 7.05%. This prediction currently runs until 06.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -0.772% | -0.772% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Barclays_PLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $446.00 to $472.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.60
11.12.23
11.12.23
€385.41
11.12.24
11.12.24
26.62%
17:24
17:24